Stock image

December 16, 2009 - Non-enhanced CT for calcium detection is a reliable way to exclude obstructive coronary artery disease in patients with chest pain, according to a study published in the December issue of the American Journal of Cardiology. While is a well established option for , particularly when stress tests are inconclusive or not feasible, Concerns surrounding radiation and contrast exposure prompted researchers, led by Dr. Koen Nieman and colleagues from Erasmus Medical Center, Rotterdam, The Netherlands, to investigate alternative diagnostic techniques for evaluating patients with chest pain other than CT angiography (CTA). To compare the effectiveness of coronary calcium scores (CCS), CTA, and exercise electrocardiography (XECG) for detecting obstructive coronary disease, researchers evaluated 471 patients with new stable chest pain. In eight patients (1.7 percent), neither CCS nor CTA was possible. In an additional eight, CTA could not be performed for various reasons. All of the calcium scans were successful, while three CTAs failed. XECG was not possible in 48 patients (10.2 percent) and was inconclusive in 140 of 423 patients (33 percent). Ninety-eight patients underwent catheter angiography, with 57 found to have at least 50 percent diameter obstruction. Overall, 175 patients (37 percent) had a negative CCS. Three of these (2 percent) had significant CAD on CT angiograms, only one of which was confirmed by quantitative angiography. In patients with a high CCS (Agatston of more than 400; n = 65), CTA could exclude obstructive CAD in no more than four (6 percent). CT was more often diagnostic in patients with a low-intermediate CCS (10 to 400; n = 175), and could rule out obstructive CAD in 56 percent of patients. Few cases of obstructive disease were detected in patients with a low CCS (less than 10; n = 48), although these patients had evidence of atherosclerotic disease. Overall, 42 percent of patients had positive CT angiograms. These patients had significant stenosis on quantitative angiogram more often when exercise electrocardiogram was also positive. For patients with diagnostic results for all tests, the sensitivity and specificity to detect significant coronary stenosis were 100 percent and 16 percent for CCS of more than zero, 82 percent and 64 percent for CCS of more than 100, 97 percent and 36 percent for CTA, and 70 percent and 76 percent for XECG, respectively. The type of tests preferred for the workup of suspected CAD - functional, or anatomical - is still up for debate. "Although XECG is considered more cost effective, it has poor diagnostic performance," the researchers noted. The researchers concluded, similar to a negative stress test result, a negative CCS also has an excellent prognosis. This suggests that a negative CCS could suffice to rule out obstructive CAD without the need for further testing. For more information:www.ajconline.org


Related Content

News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
Subscribe Now